Microbiology



Items 1 to 50 of 185 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4

Set Descending Direction
Catalog No. Product Name Application Product Information
A10908 SALE

Tenofovir (Viread)

HIV reverse transcriptase inhibitor
Tenofovir is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by decreasing the amount of HIV in the blood.
A15772

GS-7340

NRT inhibitor
GS-7340 is a prodrug of tenofovir (TFV) that more efficiently delivers TFV into lymphoid cells and tissues than TFV disoproxil fumarate.
A15428

Zidovudine

NRTI Inhibitor
Zidovudine is a nucleoside analog reverse-transcriptase inhibitor (NRTI), a type of antiretroviral drug used for the treatment of HIV/AIDS infection. Azidothymidine decreases CRISPR-mediated homology directed repair (HDR) efficiency.
A14435

Elvucitabine

NRT inhibitor
Elvucitabine is an experimental nucleoside reverse transcriptase inhibitor (NRTI).
A10512 SALE

Lamivudine

-
Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor (nRTI).
A12667

Lersivirine (UK-453061)

NNRT inhibitor
Lersivirine (UK-453,061) is a next-generation nonnucleoside reverse transcriptase inhibitor, active against wild-type HIV-1 and several nonnucleoside reverse transcriptase inhibitor-resistant strains.
A12587 SALE

Dapivirine

HIV reverse transcriptase inhibitor
Dapivirine is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI)
A10639 SALE

Nevirapine (Viramune)

-
Nevirapine (Viramune) is a potent (IC50=84nM) and selective non-nucleoside inhibitor of HIV-1 reverse transcriptase.
A12443

MK-1439

NNRT inhibitor
MK-1439 is a non-nucleoside reverse transcriptase inhibitor
A10306

Didanosine

Reverse transcriptase inhibitor
Didanosine is a reverse transcriptase inhibitor, effective against HIV and used in combination with other antiretroviral drug therapy as part of highly active antiretroviral therapy (HAART).
A11216 SALE

Entecavir

Reverse transcriptase inhibitor
Entecavir is a nucleoside analog (more specifically, a guanosine analogue) that inhibits reverse transcription, DNA replication and transcription in the viral replication process. Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection.
A10909 SALE

Tenofovir Disoproxil Fumarate

nucleotide reverse transcriptase inhibitor
Tenofovir Disoproxil Fumarate is employed as an anti-HIV agend and a reverse transcriptase inhibitor.
A11120 SALE

Abacavir sulfate

Transcriptase inhibitor
Abacavir sulfate is a nucleoside analog reverse transcriptase inhibitor (NRTI); guanosine analog used to treat HIV and AIDS.
A11115 SALE

Abacavir

Transcriptase inhibitor
Abacavir is a nucleoside analog reverse transcriptase inhibitor (NRTI); guanosine analog used to treat HIV and AIDS.
A10039 SALE

Adefovir dipivoxil

-
Adefovir dipivoxil is an orally-administered nucleotide analog reverse transcriptase inhibitor (ntRTI). It is used for treatment of hepatitis B and herpes simplex virus infection.
A11542 SALE

Rilpivirine (R 278474, TMC 278)

NNRT inhibitor
Rilpivirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.
A10349 SALE

Emtricitabine

NRT inhibitor
Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) for the treatment of HIV infection.
A16162

Dolutegravir Sodium

HIV integrase inhibitor
Dolutegravir sodium is a HIV integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.
A16018

BI 224436

HIV integrase inhibitor
BI 224436 is a novel HIV-1 non-catalytic-site integrase inhibitor; has antiviral EC50s of <15 nM against different HIV-1 laboratory strains and cellular cytotoxicity of >90 μM.
A16014

GSK744 (S/GSK1265744)

HIV integrase inhibitor
GSK744 is a potent HIV integrase inhibitor as an oral lead-in tablet and long-acting injectable for the treatment and prevention of HIV infection.
A13984

GSK1265744 (GSK744) Sodium salt

HIV Integrase Inhibitor
GSK1265744 (GSK744) is a potential inhibitor of HIV integrase with IC50 value of 3 nM
A10347 SALE

Elvitegravir (GS-9137)

HIV integrase inhibitor
Elvitegravir (GS-9137) is a potent inhibitor of the strand-transfer step of integration mediated by human immunodeficiency virus type 1 (HIV-1) integrase.
A10156

BMS-707035

HIV-1 integrase inhibitor

BMS-707035 is an HIV-1 integrase (IN) inhibitor. HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic.

A11135

MK-2048

HIV integrase inhibitor
MK-2048 is a second generation integrase inhibitor, intended to be used against HIV infection.
A11068 SALE

S/GSK1349572 (Dolutegravir)

HIV integrase inhibitor
S/GSK1349572 is a potent next generation HIV integrase inhibitor and demonstrates a superior resistance profile substantiated with 60 integrase mutant molecular clones.
A10775 SALE

Raltegravir (MK-0518)

HIV-1 integrase inhibitor
Raltegravir (MK-0518) targets integrase, an HIV enzyme that integrates the viral genetic material into human chromosomes, a critical step in the pathogenesis of HIV.
A14046

GS-9451

HCV NS3/4A protease inhibitor
GS-9451, a novel hepatitis C virus (HCV) nonstructural 3/4a (NS3/4a) protease inhibitor, is highly active in patients infected with HCV genotype 1 (GT 1).
A13965

MK 8742 (elbasvir)

HCV NS5A inhibitor
MK 8742, also known as Elbasvir, is a HCV NS5A inhibitor, which is an all-oral, interferon-free regimen for the treatment of HCV infection.
A14106

Faldaprevir

HCV Protease Inhibitor
Faldaprevir is a hepatitis C virus protease inhibitor.
A11530 SALE

PSI-6206

HCV RNA polymerase inhibitor
PSI-6206 is the deaminated derivative of PSI-6130, which is a potent inhibitor of hepatitis C virus (HCV) replication in the subgenomic HCV reolicon system.
A11529 SALE

PSI-7977

HCV Nucleotide Inhibitor
PSI-7977 is a phosphoramidate prodrug of PSI-7851, a nucleoside analog that, when phosphorylated, inhibits the RNA-dependent RNA polymerase of hepatitis C virus (EC50 = 92 nM).
A15166

MK-5172 hydrate

HCV inhibitor
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.
A15167

MK-5172 potassium salt

HCV inhibitor
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.
A15168

MK-5172 sodium salt

HCV inhibitor
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.
A15224

RO-9187

HCV replication inhibitor
RO-9187 is a potent inhibitor of HCV virus replication in the replicon system (IC(50) = 171 +/- 12 nM; CC(50) >1 mM).
A15479

VCH-759

HCV Polymerase Inhibitor
VCH-759 is a non-nucleoside inhibitor of HCV RNA-dependent polymerase with sub-micromolar IC50 values versus genotype 1a/1b replicons.
A11510

Nesbuvir

HCV Inhibitor
HCV-796 is a selectively inhibitor of hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase.
A11580

Simeprevir

HCV NS3/4A protease inhibitor
Simeprevir is a potent inhibitor of HCV NS3/4A protease (Ki = 0.36 nM) and viral replication (replicon EC50 = 7.8 nM).
A11600

Vaniprevir

HCV NS3/4A protease inhibitor
Vaniprevir is a non-covalent competitive inhibitor of the hepatitis C virus (HCV) NS3/4A protease.
A13155 SALE

Ledipasvir (GS 5885)

NS5A inhibitor
Ledipasvir is an inhibitor of the hepatitis C virus HCV NS5A protein
A13118

Celgosivir

alpha-glucosidase I inhibitor
Celgosivir is an alpha-glucosidase I inhibitor for the potential treatment of HCV infection.
A13105

Setrobuvir (ANA-598)

HCV Polymerase Inhibitor
Setrobuvir (ANA-598) is a direct-acting antiviral or DAA, is a non-nucleoside inhibitor of the HCV RNA polymerase
A10159 SALE

BMS-790052

HCV NS5A inhibitor
BMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
A10284 SALE

Danoprevir (RG7227)

HCV NS3/4A protease inhibitor
Danoprevir is a potent inhibitor of the HCV NS3/4A serine protease.
A10980

VX-222

HCV Protease inhibitor
VX-222 is a small molecule non-nucleoside inhibitor of HCV NS5B polymerase that is being investigated for the treatment of hepatitis C virus infection.
A10902 SALE

Telaprevir (VX-950)

HCV NS3-4A protease inhibitor
Telaprevir (VX-950) is known as protease inhibitors that inhibits the hepatitis C virus NS3.4A serine protease.
A11294

Anguizole

HCV replication Inhibitor
Anguizole is a small molecule inhibits HCV replication and alters NS4B's subcellular distribution.
A11295 SALE

Asunaprevir (BMS-650032)

NS3 protease inhibitor
Asunaprevir is an inhibitor of the viral enzyme serine protease NS3.
A11332 SALE

Boceprevir (SCH-503034)

HCV Protease Inhibitor
Boceprevir is a protease inhibitor used as a treatment for hepatitis C genotype 1.
A11335

Balapiravir (R1626)

Polymerase inhibitor
Balapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479).

Items 1 to 50 of 185 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4

Set Descending Direction